Episode Summary

Can blood tests tell you whether you're losing bone, building bone, or making progress with your bone health plan?

In this episode of Stronger Bones Lifestyle, Debi Robinson welcomes back Dr. Andy Bush, orthopedic surgeon and chemist, to explore bone turnover markers and what they can tell us about the body's ongoing bone remodeling process.

Dr. Bush explains the differences between CTX and NTX, which are associated with bone breakdown, and P1NP and alkaline phosphatase, which can provide information about bone formation and activity. He also discusses factors that may affect test results, why consistent testing conditions matter, and how clinicians use these markers alongside other laboratory findings and a person's medical history. The conversation also explores the limitations of current research, including proposed CTX-to-P1NP ratios that have not yet been established as reliable predictors of fracture risk.

What You'll Learn

Action Steps

Debi's Takeaway

Bone turnover markers can offer useful information, but they don't tell the whole story. We need to interpret the results carefully, understand the limitations of current research, and remember why we're gathering this information in the first place. Our goal is not just to monitor bone health—it's to support stronger bones, prevent fractures, and help women continue living active, confident lives.

Resources & Links